{"id":472627,"date":"2021-04-07T08:03:33","date_gmt":"2021-04-07T12:03:33","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=472627"},"modified":"2021-04-07T08:03:33","modified_gmt":"2021-04-07T12:03:33","slug":"x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\/","title":{"rendered":"X4 Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">BOSTON, April  07, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YyBmHUs0qZLd5gkM6Pgcfy5v3OrR7WrnYoFv9VxjfE5_UMnISwFX0PaYFRRmASHwy5EjxgWXvkCnMjAtGu-g3R6sW1WFUx2FIseOIGVvkO8=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>X4 Pharmaceuticals, Inc.<\/strong><\/a> (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of the CXCR4 pathway, today announced that management will present a corporate overview at the 20<sup>th<\/sup> Annual Needham Virtual Healthcare Conference on Monday, April 12, 2021.<\/p>\n<p>\n        <strong>Details are as follows:<\/strong><br \/>\n        <br \/>Conference: 20<sup>th<\/sup> Annual Needham Virtual Healthcare Conference <br \/>Date: Monday, April 12, 2021<br \/>Time: 2:15 PM ET<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4x6sPI5NfOJ8PdSfCyMQVmV6pG9_L3MvUKosyk4gJuKzAIlRiZQORkkpNYptO5hVCsgczxumipP7NN-Rr2YzK8vE-AdEHbmJjfe0UJKvlTLHmb_aUo4oTpKU_V-ifkjnQu-5Lig_-i6vsj8unRNL6lUNUA1fAVinup3pxDqhTbPu-NvMHmeJgaxjj4Y8W9ZC2kWPx3DrOUYAG6v592VQYgliSlmJjeA3bd7PJz_QwlvKOQ2wifqzkrj4jJjENT8TTfmHl6AcHzBKrvasuq5O5YOLVFzxWpkn3560kwTI1ePZk6BPskU_3M37NShGuRm2dnzMeVwE5KRpMhU2zVWH96bSNRPrAz0xLHPRTGtgAUsH6c5H_g0biOP9DrCYc5RtnfRmbmWH6zYj3QviyV2Ohxnsmh8y-ylC9tbykiq_RtXOwm3pySqKzcKiOiSm-79dYZE9jtnpMFXAfC0mnWW2ChJVqBCbVb1_GeSFJVBbpwoiZIjxIlh7C2kIfhS47tEuEdbn_5QDf7NOBl_UDNwnU8K-p7TjM5FGea9eHHa-EsLm7wtJrTaW19pkir7159Axav9dssES8m_MNSMDVOeMISrwCvUA02uFFmCDz5tnY_8kj08Vo2MIyFxqcwLiPsEtUuBpwzHawQ1lHjyUXTEJWA9OHlM7V4WASiKDG0LUTjGPfYuLvW88J3E2g55rZDFbabBUdj-lURd2OW5QLmpFkSzFzIdIY0TEJFK81Mw_e3ta_kM_EcMZaXSTMaWZj7SLY3krT4gPpFc_bcc2Vg9yxL3X9sO8Lq1u-Cg-FbUXTj4nmTuUkdiokx1QDkDMscZjBVT0zX1WTU9-mp3emLXROQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><em>Presentation Webcast Link<\/em><\/a><\/p>\n<p>A live webcast of the presentation from the Needham Virtual Healthcare Conference will be available on the investors section of the X4 Pharmaceuticals\u2019 website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=etOJJVWAmpXiSmurnWySLHkKXfXu9Itxx9S5dSfKvcnN46_pj90EI9Tp7BHULquKcqslgAMH9fXihSOEQM7Fqw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.x4pharma.com<\/a>.\u00a0\u00a0 After the live webcast, the event will remain archived on the X4 Pharmaceuticals\u2019 website for approximately 90 days.<\/p>\n<p>\n        <strong>About X4 Pharmaceuticals<br \/><\/strong>X4 Pharmaceuticals is a late-stage clinical biopharmaceutical company and a leader in the discovery and development of novel therapies for the treatment of diseases resulting from dysfunction of the CXCR4 pathway, with a focus on rare diseases and those with limited treatment options. The company\u2019s lead candidate, mavorixafor, is a first-in-class, small molecule antagonist of chemokine receptor CXCR4 being developed as a once-daily oral therapy. X4 believes that inhibition of the CXCR4 receptor creates the potential for mavorixafor to provide therapeutic benefit across a wide variety of diseases, including primary immunodeficiencies and certain types of cancer. The efficacy and safety of mavorixafor, dosed once daily, is currently being evaluated in a global Phase 3 clinical trial in patients with WHIM syndrome, and in two Phase 1b clinical trials \u2013 in combination with ibrutinib in patients with Waldenstr\u00f6m\u2019s macroglobulinemia, and as monotherapy in patients with Severe Congenital Neutropenia. X4 is continuing to leverage its insights into CXCR4 biology at its corporate headquarters in Boston, Massachusetts and at its research facility in Vienna, Austria, and is discovering and developing additional product candidates. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=etOJJVWAmpXiSmurnWySLEklDHjNa14L39m51O8Vwd_5vsQvmyQOUi9DGqExjOhtD4XTtQwgnF20L7TuuDsRBw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.x4pharma.com<\/a>.<\/p>\n<p>\n        <strong>Investors and Media:\u00a0<\/strong><br \/>\n        <br \/>Daniel Ferry<br \/>Managing Director <br \/>LifeSci Advisors<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BUUnDD785dZ9c0RZrpcHfaUuZ-x_fKt7NOjyNIq1goCg0pa42DUPeQKW3bj8fL2qcpDLh8EtY8oAH3mMZQLmfeOM_-8f3enczB1anP5E2ZDIcLlUTgHzbi9bDSmITFwc\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">daniel@lifesciadvisors.com<\/a><br \/>(617) 430-7576<\/p>\n<p>M\u00f3nica Rouco Molina<br \/>Senior Account Executive <br \/>LifeSci Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=P4NhWkbYsblFrf6uGlNZHhwlKswai_BBbTDd5DGdN96__ZmHsZOWjFsZzJmoDqrt9RaGdDaWL5UiDswJ_Y8Epel379te4yUCAiZEnzPbVgrIh1xMzeOWZRQNkX3AG-JM\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">mroucomolina@lifescicomms.com<\/a>\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTc4NCM0MTA2NjYwIzUwMDA3MjE4MQ==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/989f486f-76b0-4cfa-8707-6862fffe1c3e\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, April 07, 2021 (GLOBE NEWSWIRE) &#8212; X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of the CXCR4 pathway, today announced that management will present a corporate overview at the 20th Annual Needham Virtual Healthcare Conference on Monday, April 12, 2021. Details are as follows: Conference: 20th Annual Needham Virtual Healthcare Conference Date: Monday, April 12, 2021Time: 2:15 PM ETPresentation Webcast Link A live webcast of the presentation from the Needham Virtual Healthcare Conference will be available on the investors section of the X4 Pharmaceuticals\u2019 website at www.x4pharma.com.\u00a0\u00a0 After the live webcast, the event will remain archived on the X4 Pharmaceuticals\u2019 website for approximately 90 days. About X4 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;X4 Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-472627","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>X4 Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"X4 Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, April 07, 2021 (GLOBE NEWSWIRE) &#8212; X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of the CXCR4 pathway, today announced that management will present a corporate overview at the 20th Annual Needham Virtual Healthcare Conference on Monday, April 12, 2021. Details are as follows: Conference: 20th Annual Needham Virtual Healthcare Conference Date: Monday, April 12, 2021Time: 2:15 PM ETPresentation Webcast Link A live webcast of the presentation from the Needham Virtual Healthcare Conference will be available on the investors section of the X4 Pharmaceuticals\u2019 website at www.x4pharma.com.\u00a0\u00a0 After the live webcast, the event will remain archived on the X4 Pharmaceuticals\u2019 website for approximately 90 days. About X4 &hellip; Continue reading &quot;X4 Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-07T12:03:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTc4NCM0MTA2NjYwIzUwMDA3MjE4MQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"X4 Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference\",\"datePublished\":\"2021-04-07T12:03:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\\\/\"},\"wordCount\":343,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMTc4NCM0MTA2NjYwIzUwMDA3MjE4MQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\\\/\",\"name\":\"X4 Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMTc4NCM0MTA2NjYwIzUwMDA3MjE4MQ==\",\"datePublished\":\"2021-04-07T12:03:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMTc4NCM0MTA2NjYwIzUwMDA3MjE4MQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMTc4NCM0MTA2NjYwIzUwMDA3MjE4MQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"X4 Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"X4 Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"X4 Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference - Market Newsdesk","og_description":"BOSTON, April 07, 2021 (GLOBE NEWSWIRE) &#8212; X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of the CXCR4 pathway, today announced that management will present a corporate overview at the 20th Annual Needham Virtual Healthcare Conference on Monday, April 12, 2021. Details are as follows: Conference: 20th Annual Needham Virtual Healthcare Conference Date: Monday, April 12, 2021Time: 2:15 PM ETPresentation Webcast Link A live webcast of the presentation from the Needham Virtual Healthcare Conference will be available on the investors section of the X4 Pharmaceuticals\u2019 website at www.x4pharma.com.\u00a0\u00a0 After the live webcast, the event will remain archived on the X4 Pharmaceuticals\u2019 website for approximately 90 days. About X4 &hellip; Continue reading \"X4 Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-07T12:03:33+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTc4NCM0MTA2NjYwIzUwMDA3MjE4MQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"X4 Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference","datePublished":"2021-04-07T12:03:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\/"},"wordCount":343,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTc4NCM0MTA2NjYwIzUwMDA3MjE4MQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\/","name":"X4 Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTc4NCM0MTA2NjYwIzUwMDA3MjE4MQ==","datePublished":"2021-04-07T12:03:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTc4NCM0MTA2NjYwIzUwMDA3MjE4MQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTc4NCM0MTA2NjYwIzUwMDA3MjE4MQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/x4-pharmaceuticals-to-present-at-the-20th-annual-needham-virtual-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"X4 Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/472627","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=472627"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/472627\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=472627"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=472627"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=472627"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}